SW
Scott Whitcup
Founder of Akrivista and Whitecap Biosciences
Irvine, California
Overview
Scott Whitcup is the Founder and CEO of Akrivista in Irvine, California, with a notable background as the EVP of R&D and Head of Ophthalmology Therapeutic Area at Allergan. He has a strong foundation in clinical development and ophthalmology, with extensive experience in leading clinical trials and research efforts in the pharmaceutical industry.
Whitcup's career highlights include founding Akrivista and Whitecap Biosciences, as well as holding key leadership roles at Allergan and the National Eye Institute. His expertise spans various therapeutic areas, including ophthalmology, dermatology, immunology, and oncology, demonstrating a broad and impactful career in the healthcare and pharmaceutical sectors.
Work Experience
Founder and CEO
2015 - Current
Akrivista is a company focused on developing novel therapies in ophthalmology.
EVP, R&D
2004 - 2015
Head, Ophthalmology Therapeutic Area
2000 - 2004
Repros Therapeutics is focused on the development of new drugs to treat hormonal and reproductive system disorders.
Raised $29,499,310.00 from New Enterprise Associates.
Clinical Director
1993 - 2000
National Institutes of Health’s National Eye Institute is a vision research organization.
Clinical Fellow
1990 - 1992
Fellowship in Uveitis and Ocular Immunology
National Institutes of Health’s National Eye Institute is a vision research organization.
Ophthalmology Resident
1987 - 1990
Residency in Ophthalmology
Internal Medicine Resident
1984 - 1987
Residency in Internal Medicine